Medicamen Biotech Ltd. - Research Center
531146 MEDICAMEQ Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
83.17 |
66.62 |
55.39 |
60.05 |
56.89 |
Operating profit |
13.56 |
11.51 |
11.29 |
12.27 |
9.45 |
Interest |
1.86 |
1.38 |
1.06 |
0.34 |
0.62 |
Gross profit |
12.63 |
11.62 |
11.40 |
12.48 |
9.04 |
EPS (Rs) |
5.87 |
5.69 |
5.35 |
6.85 |
4.36 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
0.93 |
1.49 |
1.17 |
0.56 |
0.22 |
Stock adjustment |
-9.76 |
-3.01 |
-2.21 |
-1.12 |
0.46 |
Raw material |
53.33 |
36.47 |
28.43 |
27.26 |
35.67 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
10.47 |
9.25 |
7.46 |
7.04 |
4.33 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
15.57 |
12.39 |
10.43 |
14.61 |
6.99 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
3.48 |
3.14 |
3.09 |
2.68 |
1.39 |
Taxation |
1.73 |
1.28 |
1.77 |
1.43 |
2.32 |
Net profit / loss |
7.43 |
7.20 |
6.53 |
8.37 |
5.33 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
12.65 |
12.65 |
12.22 |
12.22 |
12.22 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
16.31 |
17.28 |
20.38 |
20.43 |
16.60 |
GPM (%) |
15.02 |
17.06 |
20.15 |
20.59 |
15.84 |
NPM (%) |
8.83 |
10.57 |
11.55 |
13.82 |
9.33 |